Last reviewed · How we verify

NCT04218149

Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery

Completed Phase 4 Last updated 31 January 2020
What this trial tests

Phase 4 trial testing Bupivacaine Injection in Breast Cancer in 70 participants. Completed in 1 October 2019.

Timeline
1 May 2019
Primary endpoint
29 September 2019
1 October 2019

Quick facts

Lead sponsorSisli Hamidiye Etfal Training and Research Hospital
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment70
Start date1 May 2019
Primary completion29 September 2019
Estimated completion1 October 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

Adults 18 to 65, female only, with Breast Cancer or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interfacial plan blocks are becoming more widely used for postoperative analgesia because of their easier applicability and less risk of complications. In this study, we aimed to compare the effects of serratus plane block (SPB) and erector spinae plane block (ESPB) on postoperative analgesia in patients undergoing unilateral breast surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bupivacaine Injection

Trials testing the same drug.

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04218149.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing